Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Costanza Simoncini

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Frontiers in Neurology|October 29, 2020
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1Costanza Simoncini, Giulia Spadoni, Elisa Lai, et al.
The Neurologist|November 2, 2012
Fabry disease with atypical neurological presentation: report of a caseCostanza Simoncini, Daniele Orsucci, Sara Gori, et al.
International Journal of Alzheimer'S Disease|March 23, 2011
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?Elena Caldarazzo Ienco, Costanza Simoncini, Daniele Orsucci, et al.
Mitochondrion|July 26, 2016
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELASElena Caldarazzo Ienco, Daniele Orsucci, Costanza Simoncini, et al.
Neuroimage. Clinical|July 21, 2016
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1Sigrid Baldanzi, Paolo Cecchi, Serena Fabbri, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|May 21, 2016
A multi-parametric protocol to study exercise intolerance in McArdle's diseaseGiulia Ricci, Federica Bertolucci, Annalisa Logerfo, et al.
Neuromuscular Disorders : NMD|April 11, 2018
Disruption of sleep-wake continuum in myotonic dystrophy type 1: Beyond conventional sleep stagingEnrica Bonanni, Luca Carnicelli, Davide Crapanzano, et al.
Orphanet Journal of Rare Diseases|April 6, 2016
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional studySigrid Baldanzi, Francesca Bevilacqua, Rita Lorio, et al.
Medical & Biological Engineering & Computing|August 22, 2017
Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocolCostanza Simoncini, Krzysztof Jurczuk, Daniel Reska, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 7, 2020
Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletionsPatrizia Formichi, Nastasia Cardone, Ilaria Taglia, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|October 29, 2020
Central Nervous System Involvement as Outcome Measure for Clinical Trials Efficacy in Myotonic Dystrophy Type 1Costanza Simoncini, Giulia Spadoni, Elisa Lai, et al.
The Neurologist|November 2, 2012
Fabry disease with atypical neurological presentation: report of a caseCostanza Simoncini, Daniele Orsucci, Sara Gori, et al.
International Journal of Alzheimer'S Disease|March 23, 2011
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease?Elena Caldarazzo Ienco, Costanza Simoncini, Daniele Orsucci, et al.
Mitochondrion|July 26, 2016
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELASElena Caldarazzo Ienco, Daniele Orsucci, Costanza Simoncini, et al.
Neuroimage. Clinical|July 21, 2016
Relationship between neuropsychological impairment and grey and white matter changes in adult-onset myotonic dystrophy type 1Sigrid Baldanzi, Paolo Cecchi, Serena Fabbri, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|May 21, 2016
A multi-parametric protocol to study exercise intolerance in McArdle's diseaseGiulia Ricci, Federica Bertolucci, Annalisa Logerfo, et al.
Neuromuscular Disorders : NMD|April 11, 2018
Disruption of sleep-wake continuum in myotonic dystrophy type 1: Beyond conventional sleep stagingEnrica Bonanni, Luca Carnicelli, Davide Crapanzano, et al.
Orphanet Journal of Rare Diseases|April 6, 2016
Disease awareness in myotonic dystrophy type 1: an observational cross-sectional studySigrid Baldanzi, Francesca Bevilacqua, Rita Lorio, et al.
Medical & Biological Engineering & Computing|August 22, 2017
Towards a patient-specific hepatic arterial modeling for microspheres distribution optimization in SIRT protocolCostanza Simoncini, Krzysztof Jurczuk, Daniel Reska, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 7, 2020
Fibroblast growth factor 21 and grow differentiation factor 15 are sensitive biomarkers of mitochondrial diseases due to mitochondrial transfer-RNA mutations and mitochondrial DNA deletionsPatrizia Formichi, Nastasia Cardone, Ilaria Taglia, et al.
Pageof 3